)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
Omeros
Omeros (OMER) investor relations material
Omeros AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary18 Jun, 2026
Opening remarks and agenda
Meeting opened with introductions of board members, auditor, and Inspector of Elections, and outlined agenda and rules for Q&A, emphasizing orderly conduct and forward-looking statement disclaimers.
Overview of voting outcomes
Quorum established with approximately 80% of shares represented.
Election of three Class II directors approved for terms until 2029.
Say on Pay resolution and amended Omnibus Incentive Compensation Plan approved.
Ratification of Ernst & Young as independent auditor for 2026 confirmed.
Financial performance review
Balance sheet materially strengthened through the Novo Nordisk transaction, providing $240M upfront, $100M near-term milestones, and up to $1.71B in potential milestones and royalties.
Significant debt retired, leaving only 2029 convertible notes; agreement to repurchase up to $16M in principal announced.
Company targets positive cash flow by mid-2027, supported by strong working capital.
YARTEMLEA launch became cash flow positive in Q1 2026.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Omeros
- YARTEMLEA launch drove $9.9M sales, $56.1M net income, and strong liquidity in Q1 2026.OMER
Q1 202620 May 2026 - FDA approval, asset sale, and strengthened governance drive major 2025 milestones.OMERProxy filing30 Apr 2026
- Major asset sale and YARTEMLEA launch drove profitability and rapid market adoption.OMERQ4 202531 Mar 2026
- Q3 net loss narrowed to $32.2M, but going concern risk persists as cash burn and debt remain high.OMERQ3 202413 Feb 2026
- Q2 net loss rose on one-time costs; debt cut, OMIDRIA royalties up, clinical pipeline advanced.OMERQ2 20242 Feb 2026
- FDA approved YARTEMLEA for TA-TMA, launching January 2026 with strong efficacy and safety.OMERFDA Announcement8 Jan 2026
- Q4 net loss narrowed, cash at $90.1M, and major clinical milestones expected in 2025.OMERQ4 202419 Dec 2025
- Proxy covers director elections, executive pay, auditor ratification, and 2024 business highlights.OMERProxy Filing2 Dec 2025
- Net loss narrowed, debt restructured, but liquidity risks remain as focus shifts to narsoplimab.OMERQ1 202526 Nov 2025
Next Omeros earnings date
Q2 202613 Aug, 2026
Omeros
Next Omeros earnings date
Q2 202613 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage